Innoviva Inc risk profile

33 Normal where most of the sector sits

Measured 21 October 2026 from INVA's filed statements. Recomputed nightly.

33 (Normal), driven by Competitive position at 42, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation30NormalStableOne-year price volatility — 27.5%
Operating pressureReads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company.
Cash conversion28NormalWorseningCash conversion — 0.73x
Leverage and coverage0ContainedEasingNet debt to EBITDA — -0.79x
Competitive position42ElevatedStableRevenue-growth gap against peers — -11.9 percentage points
Concentration39NormalEasingCustomer concentration — 1,544 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Innoviva Inc